These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9274650)

  • 61. Which 5-ASA?
    Mansfield JC
    Gut; 2003 May; 52(5):771. PubMed ID: 12692073
    [No Abstract]   [Full Text] [Related]  

  • 62. Distinguishing Epidermolysis Bullosa Acquisita From Bullous Pemphigoid Without Direct Immunofluorescence.
    Gardner KM; Crawford RI
    J Cutan Med Surg; 2018; 22(1):22-24. PubMed ID: 28719980
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Liver Transplant in a Patient With Acquired Epidermolysis Bullosa and Associated End-Stage Liver Disease.
    Vennarecci G; Miglioresi L; Guglielmo N; Pelle F; Santoro R; Andreuccetti J; Ceribelli C; Stella P; Angelo C; Ettorre GM
    Exp Clin Transplant; 2017 Jun; 15(3):366-368. PubMed ID: 26671706
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A Case Report of the Use of Rituximab and the Epidermolysis Bullosa Disease Activity Scoring Index (EBDASI) in a Patient with Epidermolysis Bullosa Acquisita with Extensive Esophageal Involvement.
    Yang A; Kim M; Craig P; Murrell DF
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):325-328. PubMed ID: 30665483
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Time-course of the change in titre of antibodies against type VII collagen in a patient with epidermolysis bullosa acquisita.
    Sato M; Ishitsuka A; Shibuya Y; Kanoh H; Koga H; Hashimoto T; Seishima M
    Acta Derm Venereol; 2012 Nov; 92(6):693-4. PubMed ID: 22434144
    [No Abstract]   [Full Text] [Related]  

  • 66. Management of epidermolysis bullosa acquisita.
    Intong LR; Murrell DF
    Dermatol Clin; 2011 Oct; 29(4):643-7. PubMed ID: 21925011
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Double-blind comparative study of sulfasalazine and controlled-release mesalazine tablets in the treatment of active ulcerative colitis.
    Munakata A; Yoshida Y; Muto T; Tsuchiya S; Fukushima T; Hiwatashi N; Kobayashi K; Kitano A; Shimoyama T; Inoue M
    J Gastroenterol; 1995 Nov; 30 Suppl 8():108-11. PubMed ID: 8563868
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A case of epidermolysis bullosa acquisita with clinical features of Brunsting-Perry pemphigoid showing an excellent response to colchicine.
    Tanaka N; Dainichi T; Ohyama B; Yasumoto S; Oono T; Iwatsuki K; Elfert S; Fritsch A; Bruckner-Tuderman L; Hashimoto T
    J Am Acad Dermatol; 2009 Oct; 61(4):715-9. PubMed ID: 19679376
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A case of epidermolysis bullosa acquisita with unusual clinical features.
    Furukita K; Ansai S; Hida Y; Kubo Y; Arase S; Hashimoto T
    Clin Exp Dermatol; 2009 Dec; 34(8):e702-4. PubMed ID: 19817767
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Could cytomegalovirus infection play a causative role in epidermolysis bullosa acquisita?
    Piccolo V; Moscarella E; Errico M; Russo T; Tripodi Cutrì F; Ametrano O; Pellegrini F; Picciocchi R
    Eur J Dermatol; 2011; 21(4):607-8. PubMed ID: 21659069
    [No Abstract]   [Full Text] [Related]  

  • 71. [Mesalazine old and new].
    Mañosa M; Domènech E
    Gastroenterol Hepatol; 2011 Dec; 34 Suppl 3():25-9. PubMed ID: 25443223
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sustained clinical remission for 5 years in severe epidermolysis bullosa acquisita following rituximab infusions.
    Koszegi B; Stone C; Ishii N; Hashimoto T; Murrell DF
    J Eur Acad Dermatol Venereol; 2024 Sep; 38(9):e747-e749. PubMed ID: 38357844
    [No Abstract]   [Full Text] [Related]  

  • 73. Comment on 'Onset of epidermolysis bullosa acquisita under therapy with ustekinumab for the treatment of Crohn disease'.
    Martora F; Battista T; Potestio L; Scalvenzi M; Nappa P; Megna M
    Clin Exp Dermatol; 2023 Jul; 48(8):930-931. PubMed ID: 36994825
    [No Abstract]   [Full Text] [Related]  

  • 74. Epidermolysis bullosa acquisita in a patient with psoriasis vulgaris.
    Min L; Kensuke M; Takashi H; Naoyuki H
    Eur J Dermatol; 2015; 25(5):499-500. PubMed ID: 26243636
    [No Abstract]   [Full Text] [Related]  

  • 75. A case of mixed bullous disease of epidermolysis bullosa acquisita and linear IgA bullous dermatosis.
    Osawa M; Demitsu T; Toda S; Yokokura H; Umemoto N; Yamada T; Yoneda K; Kakurai M; Yoshida M; Hashimoto T
    Dermatology; 2005; 211(2):146-8. PubMed ID: 16088162
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
    Nakajima H; Munakata A; Yoshida Y
    J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inflammatory epidermolysis bullosa acquisita mimicking toxic epidermal necrolysis and dermatitis herpetiformis.
    Madan V; Jamieson LA; Bhogal BS; Wong CS
    Clin Exp Dermatol; 2009 Dec; 34(8):e705-8. PubMed ID: 19663858
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Regarding Martenson et al., IJROBP 35:299-303; 1996.
    Michalowski AS
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1285-6. PubMed ID: 8985061
    [No Abstract]   [Full Text] [Related]  

  • 79. Successful treatment of epidermolysis bullosa acquisita with mesalazine.
    Robinowitz BN; Towery DS; Meyers SW; Durick WJ; Taira JW
    Br J Dermatol; 1997 Jul; 137(1):154-5. PubMed ID: 9274650
    [No Abstract]   [Full Text] [Related]  

  • 80. Epidermolysis bullosa acquisita responsive to dapsone therapy.
    Hughes AP; Callen JP
    J Cutan Med Surg; 2001; 5(5):397-9. PubMed ID: 11907850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.